Loading
Alzheimer Disease / Hearing Loss / Health Education Intervention · Interventional Study
ClinicalTrials.gov · August 12, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a clinical trial registration for the Early Age-Related Hearing Loss Investigation (EARHLI), a single-site randomized interventional study designed to investigate whether hearing intervention (hearing aids) reduces cognitive decline in late middle-age adults at risk for Alzheimer's disease. No results are reported in this registry record; the study is actively recruiting and will follow participants for 1 year with multiple cognitive, functional, and neuroimaging outcome measures.
Interventional, Randomized, Parallel, Double masking, Treatment purpose. Alzheimer Disease, Hearing Loss, Cognitive Impairment; age from 55 Years; to 75 Years. Intervention: Hearing Intervention; Health Education Intervention. Compared with: Health education intervention. n = 150. 1 site: United States.
This is a clinical trial registration for the Early Age-Related Hearing Loss Investigation (EARHLI), a single-site randomized interventional study designed to investigate whether hearing intervention (hearing aids) reduces cognitive decline in late middle-age adults at risk for Alzheimer's disease. No results are reported in this registry record; the study is actively recruiting and will follow participants for 1 year with multiple cognitive, functional, and neuroimaging outcome measures.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
No clinical impact can be assessed from this registry record, as results are not yet reported. Readers should monitor this study for future publication of results to determine whether hearing intervention reduces cognitive decline in at-risk populations.
This is a clinical trial registration for an ongoing interventional study with no results reported; it describes planned enrollment and outcome measures only.
As stated by the source record.
Quoted from the source exactly as published.
No clinical impact can be assessed from this registry record, as results are not yet reported. Readers should monitor this study for future publication of results to determine whether hearing intervention reduces cognitive decline in at-risk populations.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT06174038). This is a study registration, not published results. Lead sponsor: Columbia University. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 150 participants (ESTIMATED). Conditions: Alzheimer Disease, Hearing Loss, Cognitive Impairment. Interventions: DEVICE: Hearing Intervention; BEHAVIORAL: Health Education Intervention. Primary outcome measures: Free and Cued Selective Reminding Test (FC-SRT) Score , Week 0, Week 28, Week 52; Delayed Recall Log Memory IIa, (DRLM) Score , Week 0, Week 28, Week 52; Digit Symbol Substitution Test, (DSST) Score , Week 0, Week 28, Week 52; Mini-Mental State Examination 2, (MMSE-2) Score , Week 0, Week 28, Week 52; Trail Making Test Part B, (TMTB) Score , Week 0, Week 28, Week 52; Activities of Daily Living for Mild Cognitive Impairment, (ADCS-ADLPI) Score , Week 0, Week 28, Week 52; Social Activity Frequency , Week 0, Week 28, Week 52; Ability to Participate in Social Roles and Activities (APSR) Score , Week 0, Week 28, Week 52; Community Integration Measure (CIM) Score , Week 0, Week 28, Week 52; Cohens Social Network Index (SNI) Score , Week 0, Week 28, Week 52; University of California Loneliness Scale (ULS) Score , Week 0, Week 28, Week 52; Brain MRI Measures , Week 0, Week 52. Brief summary: Early Age-Related Hearing Loss Investigation (EARHLI) is a single site study that will randomize late middle age adults to either a hearing intervention (including hearing aids) or a health education intervention. Participants will be followed for 1 year. This study will provide information on reducing cognitive decline in those at risk for Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD).
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.